Key Points Chesapeake sold 9,875 Eli Lilly and Company shares; estimated trade value of approximately $7.68 million, based on the average price for Q2 2025 Transaction represented 6.9% of fund AUM.

Independence Bank of Kentucky disclosed a purchase of 4,193 shares of Eli Lilly and Company (NYSE: LLY), estimated at $3.12 ...

Analysts have set 12-month price targets for Eli Lilly, revealing an average target of $934.09, a high estimate of $1135.00, ...

Berenberg Bank reissued their hold rating on shares of Eli Lilly and Company (NYSE:LLY – Free Report) in a research note issued to investors on Wednesday morning, MarketBeat Ratings reports. They ...

Wall Street Zen cut shares of Eli Lilly and Company (NYSE:LLY – Free Report) from a strong-buy rating to a buy rating in a research report released on Saturday. Several other equities research ...

For many Americans, a trip to the pharmacy means the stresses of figuring out which drugs are covered or how to afford those ...

U.S. pharmaceutical giant Eli Lilly and Company has announced plans to invest over $1 billion in Telangana, strengthening ...

Medtronic’s acquisition of Companion Medical brought a smart insulin pen, the InPen, into its diabetes care lineup.

Lilly's orforglipron shows superior weight loss and blood sugar control Highest dose of the pill leads to 9.2% weight reduction Detailed trial results to be presented at future medical meeting The ...

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...